{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:02:56Z","timestamp":1791874976255,"version":"4.3.4"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02189","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T04:12:27Z","timestamp":1537935147000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling"],"prefix":"10.3389","volume":"9","author":[{"given":"Elise V.","family":"Mike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadijat M.","family":"Makinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gulinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav T.","family":"Gadhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Cuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Sem Arthr Rheumat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rdc.2009.12.005","article-title":"Changing worldwide epidemiology of systemic lupus erythematosus","volume":"36","author":"Vasudevan","year":"2010","journal-title":"Rheum Dis Clin North Am."},{"key":"B3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity","year":"2015","journal-title":"BMC Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bbalip.2008.07.003","article-title":"The vascular S1P gradient-cellular sources and biological significance","volume":"1781","author":"Hla","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/intimm\/dxn023","article-title":"Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure","volume":"20","author":"Metzler","year":"2008","journal-title":"Int Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2006.06.023","article-title":"Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice","volume":"179","author":"Ma","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin Neuropharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1124\/jpet.102.045658","article-title":"Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment","volume":"305","author":"Fujino","year":"2003","journal-title":"J Pharmacol Exp Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2004.04.015","article-title":"Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice","volume":"153","author":"Webb","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B14","first-page":"439","article-title":"FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration","volume":"2","author":"Kataoka","year":"2005","journal-title":"Cell Mol Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1750-3639.2008.00182.x","article-title":"FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage","volume":"19","author":"Foster","year":"2009","journal-title":"Brain Pathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/cmdc.201000477","article-title":"BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distribution","volume":"6","author":"Briard","year":"2011","journal-title":"ChemMedChem"},{"key":"B19","first-page":"379","article-title":"Brain distribution of BZM055, an analog of fingolimod (FTY720), in human","volume":"18","author":"Tamagnan","year":"2012","journal-title":"Mult Scler J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","article-title":"The direct effects of fingolimod in the central nervous system: implications for relapsing multiple sclerosis","volume":"30","author":"Hunter","year":"2016","journal-title":"CNS Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jns.2016.03.024","article-title":"Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: an analysis from the EPOC (Evaluate Patient OutComes) trial","volume":"365","author":"Hunter","year":"2016","journal-title":"J Neurol Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0121488","DOI":"10.1371\/journal.pone.0121488","article-title":"Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis","volume":"10","author":"Nishihara","year":"2015","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.24217","article-title":"Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide","volume":"76","author":"Colombo","year":"2014","journal-title":"Ann Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2012.10.004","article-title":"Fingolimod protects cultured cortical neurons against excitotoxic death","volume":"67","author":"Di Menna","year":"2013","journal-title":"Pharmacol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0006-8993(91)91192-4","article-title":"Spatial learning, discrimination learning, paw preference and neocortical ectopias in two autoimmune strains of mice","volume":"562","author":"Denenberg","year":"1991","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0165-5728(91)90164-3","article-title":"Inflammatory central nervous system disease in lupus-prone MRL\/lpr mice: comparative histologic and immunohistochemical findings","volume":"35","author":"Vogelweid","year":"1991","journal-title":"J Neuroimmunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/art.1780370617","article-title":"Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus","volume":"37","author":"Vogelweid","year":"1994","journal-title":"Arthritis Rheum"},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00688187","article-title":"Neuroanatomical anomalies in autoimmune mice","volume":"74","author":"Sherman","year":"1987","journal-title":"Acta Neuropathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.autrev.2014.08.015","article-title":"Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model","volume":"13","author":"Jeltsch-David","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2008.11.009","article-title":"Depression is an early disease manifestation in lupus-prone MRL\/lpr mice","volume":"207","author":"Gao","year":"2009","journal-title":"J Neuroimmunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0031-9384(94)90309-3","article-title":"Disturbed emotionality in autoimmune MRL-lpr mice","volume":"56","author":"Sakic","year":"1994","journal-title":"Physiol Behav."},{"key":"B33","first-page":"2199","article-title":"Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus","volume":"33","author":"Ballok","year":"2006","journal-title":"J Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"207504","DOI":"10.1155\/2011\/207504","article-title":"The MRL\/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus","volume":"2011","author":"Gulinello","year":"2011","journal-title":"J Biomed Biotechnol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jneumeth.2013.12.010","article-title":"Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice","volume":"224","author":"Brodkin","year":"2014","journal-title":"J Neurosci Methods"},{"key":"B36","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/PL00005603","article-title":"Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix","volume":"113","author":"Ennaceur","year":"1997","journal-title":"Exp Brain Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.pbb.2009.10.008","article-title":"Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats","volume":"94","author":"Li","year":"2010","journal-title":"Pharmacol Biochem Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","article-title":"The Reactome pathway knowledgebase","volume":"42","author":"Croft","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The reactome pathway knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J Autoimmun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.24519","article-title":"Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus","volume":"61","author":"Bachen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"key":"B46","first-page":"707","article-title":"Effects of FTY720 in MRL-lpr\/lpr mice: therapeutic potential in systemic lupus erythematosus","volume":"29","author":"Okazaki","year":"2002","journal-title":"J Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/jnr.23799","article-title":"Effects of fingolimod administration in a genetic model of cognitive deficits","volume":"95","author":"Becker-Krail","year":"2017","journal-title":"J Neurosci Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s12031-013-9979-6","article-title":"FTY720 (fingolimod) attenuates beta-amyloid peptide (Abeta42)-induced impairment of spatial learning and memory in rats","volume":"50","author":"Asle-Rousta","year":"2013","journal-title":"J Mol Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0361-9230(96)00190-6","article-title":"Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study","volume":"41","author":"Sakic","year":"1996","journal-title":"Brain Res Bull."},{"key":"B52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1126\/science.156.3771.21","article-title":"Biogenic amines and emotion","volume":"156","author":"Schildkraut","year":"1967","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","article-title":"Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells","volume":"34","author":"Xia","year":"1996","journal-title":"Immunopharmacology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nn.3728","article-title":"Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory","volume":"17","author":"Hait","year":"2014","journal-title":"Nat Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/npp.2012.73","article-title":"Epigenetics of the depressed brain: role of histone acetylation and methylation","volume":"38","author":"Sun","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e00135","DOI":"10.1002\/prp2.135","article-title":"Antidepressant activity of fingolimod in mice","volume":"3","author":"di","year":"2015","journal-title":"Pharmacol Res Perspect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoim Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0022-3476(75)80831-6","article-title":"The choroid plexus in CNS involvement of systemic lupus erythematosus","volume":"87","author":"Gershwin","year":"1975","journal-title":"J Pediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"16467","DOI":"10.1523\/JNEUROSCI.2582-14.2014","article-title":"Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns","volume":"34","author":"Yang","year":"2014","journal-title":"J Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2013.00484","article-title":"Neuropsychiatric lupus, the blood brain barrier, and the TWEAK\/Fn14 Pathway","volume":"4","author":"Stock","year":"2013","journal-title":"Front Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1468-1331.2004.00976.x","article-title":"Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors","volume":"12","author":"Omdal","year":"2005","journal-title":"Eur J Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00415-014-7406-8","article-title":"Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review","volume":"261","author":"Sciascia","year":"2014","journal-title":"J Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2012.12.014","article-title":"Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE","volume":"333","author":"Moreno","year":"2013","journal-title":"J Neurol Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"383087","DOI":"10.1155\/2011\/383087","article-title":"Animal models of MS reveal multiple roles of microglia in disease pathogenesis","volume":"2011","author":"Gao","year":"2011","journal-title":"Neurol Res Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/hipo.10205","article-title":"Hippocampal damage in mouse and human forms of systemic autoimmune disease","volume":"14","author":"Ballok","year":"2004","journal-title":"Hippocampus"},{"key":"B69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molimm.2012.06.009","article-title":"Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier","volume":"53","author":"Wang","year":"2013","journal-title":"Mol Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/acn3.84","article-title":"Immunomodulatory activity of interferon-beta","volume":"1","author":"Kasper","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/glia.23028","article-title":"Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease","volume":"64","author":"Main","year":"2016","journal-title":"Glia"},{"key":"B73","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00702-017-1745-4","article-title":"Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease","volume":"125","author":"Taylor","year":"2018","journal-title":"J Neural Transm."},{"key":"B74","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-015-0427-0","article-title":"Endogenous IFN-beta signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia","volume":"12","author":"Inacio","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.brainres.2007.08.055","article-title":"Interferon-beta is neuroprotective against the toxicity induced by activated microglia","volume":"1179","author":"Jin","year":"2007","journal-title":"Brain Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0961203306073136","article-title":"New immunosuppresor strategies in the treatment of murine lupus nephritis","volume":"16","author":"Alperovich","year":"2007","journal-title":"Lupus"},{"key":"B77","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.bbrc.2010.03.078","article-title":"FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice","volume":"394","author":"Ando","year":"2010","journal-title":"Biochem Biophys Res Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2018.00487","article-title":"A distinct T follicular helper cell subset infiltrates the brain in murine neuropsychiatric lupus","volume":"9","author":"Jain","year":"2018","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12974-016-0537-3","article-title":"B cell and\/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus","volume":"13","author":"Wen","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","article-title":"FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus","volume":"70","author":"Shi","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s002130100687","article-title":"Limitations on the use of the C57BL\/6 mouse in the tail suspension test","volume":"155","author":"Mayorga","year":"2001","journal-title":"Psychopharmacology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e3347","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-Loyo","year":"2008","journal-title":"PLoS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","article-title":"Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study","volume":"28","author":"Hirohata","year":"2009","journal-title":"Clin Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/268436","article-title":"Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus","author":"Okamoto","year":"2010","journal-title":"J Biomed Biotechnol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/0961203315610206","article-title":"Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus","volume":"25","author":"Fragoso-Loyo","year":"2016","journal-title":"Lupus"},{"key":"B86","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature22821","article-title":"Microglia-dependent synapse loss in type I interferon-mediated lupus","volume":"546","author":"Bialas","year":"2017","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2013.04.002","article-title":"CNS-specific T cells shape brain function via the choroid plexus","volume":"34","author":"Baruch","year":"2013","journal-title":"Brain Behav Immun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0133392","DOI":"10.1371\/journal.pone.0133392","article-title":"Sphingosine 1 phosphate at the blood brain barrier: can the modulation of S1P receptor 1 influence the response of endothelial cells and astrocytes to inflammatory stimuli?","volume":"10","author":"Spampinato","year":"2015","journal-title":"PLoS ONE"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1038\/tp.2015.179","article-title":"Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory","volume":"5","author":"Efstathopoulos","year":"2015","journal-title":"Transl Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T04:12:32Z","timestamp":1537935152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2018.02189"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02189","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"article-number":"2189"}}